Equifax reported Q2 2026 revenue of $1.700B, up 11% (10% in local currency), with adjusted EPS of $2.25 (+13%). The company highlighted a 16% new product Vitality Index (above its 10% long-term goal) and is doubling its 2026-2028 AI-driven cost reduction target to $150M while returning $366M to shareholders (including $300M of buybacks for 1.8M shares and $66M in dividends). Equifax also signed an agreement to acquire Mexico’s Círculo de Crédito for an enterprise value of $750M, expected to close in Q4 2026; Q3/FY guidance implies continued mid-to-high single digit local currency growth with FY 2026 revenue of $6.71B–$6.78B.
The cleaner read is that the market is getting a higher-quality revenue mix story, not just a cyclical pop. EFX’s verification and data products look increasingly insulated from pure mortgage volume because the company is layering AI into workflow, pricing, and product development; if that translates, the long-duration winner is not the quarter but the multiple, since recurring, embedded decisioning revenue deserves a premium to commoditized bureau data.
The main second-order loser is anyone still competing on generic credit pull economics. If EFX can keep accelerating product vitality while pushing AI cost savings into the back half, smaller or less diversified competitors face a worse mix of price pressure and customer churn, especially in employer verification and lending onboarding. The Mexico acquisition adds a regional growth leg, but it also expands integration and regulatory complexity; that matters because any misstep would show up first in margin, not top-line.
The near-term risk is that investors over-rotate on mortgage strength and underweight the fact that normalized earnings still depend on expense control and litigation clean-up. Over the next 1-3 months, the key test is whether guidance implies real operating leverage rather than just revenue seasonality; over 6-18 months, the question is whether mortgage and consumer lending remain supportive once rates stop helping comps. The contrarian view is that the settlement overhang is not just noise: repeated legal charges can cap the valuation if they keep offsetting otherwise solid growth.
Consensus may be missing that the best part of the story is the stickiness of workflow and government contracts, not mortgage. If management executes, EFX can rerate on durable FCF expansion even if mortgage decelerates; if not, this is just a better version of a cyclical data vendor. What would falsify the thesis is a Q3 margin guide that fails to improve despite the new cost targets, or any sign that AI spend is front-loading costs without measurable productivity gains.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
